B. Emsen Et Al. , "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.5, pp.941-951, 2018
Emsen, B. Et Al. 2018. The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.5 , 941-951.
Emsen, B., Aslan, A., Turkez, H., Joughi, A. T., & Kaya, A., (2018). The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.5, 941-951.
Emsen, Bugrahan Et Al. "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.5, 941-951, 2018
Emsen, Bugrahan Et Al. "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.5, pp.941-951, 2018
Emsen, B. Et Al. (2018) . "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.5, pp.941-951.
@article{article, author={Bugrahan Emsen Et Al. }, title={The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma}, journal={JOURNAL OF CANCER RESEARCH AND THERAPEUTICS}, year=2018, pages={941-951} }